Postgraduate Medicine

Papers
(The H4-Index of Postgraduate Medicine is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Associations of serum calcium/magnesium ratios with coronary artery disease in diabetes: a cross-sectional study126
Impact of chronic medications in the perioperative period –anesthetic implications (Part II)113
Exploring the wider benefits of semaglutide treatment in obesity: insight from the STEP program93
A different outlook to consequences of anemia in older adults64
Unlocking the diagnostic potential of parathormone washout: a path to accurate parathyroid tumor localization43
Eosinophilic granulomatosis with polyangiitis41
Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years40
Effect of berberine and bicyclol on Chinese patients with nonalcoholic fatty liver disease: a retrospective study39
Reliability of transcutaneous hemoglobin measurements in an outpatient pediatric clinic32
Introduction to Hospital Medicine30
Junctional ectopic tachycardia revisited30
Updates in the diagnosis and management of Takayasu’s arteritis29
A randomized controlled trial concerning the implementation of the postural Mézières treatment in elite athletes with low back pain27
Abstracts from the 19th Annual Cardiometabolic Health Congress26
LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals26
Cardiometabolic risk factors efficacy of semaglutide in the STEP program25
Plasma: indications, controversies, and opportunities23
The cardiovascular effects of large hiatal hernias: a narrative review of cases and studies23
Association between serum vitamin C and chronic kidney disease among adults in NHANES, 2017-201820
Role of RAGE and its ligand HMGB1 in the development of COPD19
0.10477995872498